Ditchcarbon
  • Customers
  1. Organizations
  2. Genus
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated a month ago

Genus

Company website

Genus plc, commonly referred to as Genus, is a leading global player in the biotechnology industry, headquartered in Great Britain. Founded in 1938, the company has established itself as a pioneer in animal genetics, focusing on improving livestock productivity and sustainability. With major operations across North America, Europe, and Asia, Genus is dedicated to advancing agricultural practices through innovative breeding solutions. The company offers a range of core products and services, including genetic improvement programmes for cattle and pigs, which are distinguished by their emphasis on health, efficiency, and environmental sustainability. Genus has achieved notable milestones, such as being the first to introduce genomic selection in livestock, solidifying its market position as a trusted partner for farmers worldwide. With a commitment to research and development, Genus continues to lead the way in enhancing food security and animal welfare.

DitchCarbon Score

How does Genus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

44

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Genus's score of 44 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

67%

Let us know if this data was useful to you

Genus's reported carbon emissions

In 2025, Genus reported total carbon emissions of approximately 1,043,430 kg CO2e, comprising 533,040 kg CO2e from Scope 1, 125,690 kg CO2e from Scope 2, and 384,700 kg CO2e from Scope 3 emissions. In 2024, emissions were slightly higher at about 1,064,690 kg CO2e, with Scope 1 emissions at 556,620 kg CO2e, Scope 2 at 134,060 kg CO2e, and Scope 3 at 374,010 kg CO2e. For 2023, the global emissions totalled approximately 90,908,000 kg CO2e, with Scope 1 emissions at 67,601,000 kg CO2e, Scope 2 at 9,765,000 kg CO2e, and Scope 3 at 13,542,000 kg CO2e. In the UK, Genus reported 3,086,000 kg CO2e in total emissions for 2023, with Scope 2 emissions alone accounting for 162,000 kg CO2e. The company has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or SBTi commitments. Genus's emissions data is not cascaded from any parent company, and all figures are independently reported. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201820192020202120222023
Scope 1
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
8,398,000
0,000,000
0,000,000
0,000,000
00,000,000
0,000,000
Scope 3
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genus's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genus is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Genus is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Heska Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Nutreco

NL
•
Food products nec
Updated 4 days ago

Pahc

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Cargill

US
•
Food products nec
Updated 2 days ago

Neogen

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Elanco

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy